Evidence-Based Medicine Guidelines
Antifibrinolytics for heavy menstrual bleeding
Antifibrinolytics for heavy menstrual bleeding is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrinolytics for Heavy Menstrual Bleeding." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450010/all/Antifibrinolytics_for_heavy_menstrual_bleeding.
Antifibrinolytics for heavy menstrual bleeding. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450010/all/Antifibrinolytics_for_heavy_menstrual_bleeding. Accessed July 6, 2022.
Antifibrinolytics for heavy menstrual bleeding. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450010/all/Antifibrinolytics_for_heavy_menstrual_bleeding
Antifibrinolytics for Heavy Menstrual Bleeding [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 July 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450010/all/Antifibrinolytics_for_heavy_menstrual_bleeding.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrinolytics for heavy menstrual bleeding
ID - 450010
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450010/all/Antifibrinolytics_for_heavy_menstrual_bleeding
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
